909 related articles for article (PubMed ID: 1647821)
1. Omeprazole and bafilomycin, two proton pump inhibitors: differentiation of their effects on gastric, kidney and bone H(+)-translocating ATPases.
Mattsson JP; Väänänen K; Wallmark B; Lorentzon P
Biochim Biophys Acta; 1991 Jun; 1065(2):261-8. PubMed ID: 1647821
[TBL] [Abstract][Full Text] [Related]
2. [3H]Bafilomycin as a probe for the transmembrane proton channel of the osteoclast vacuolar H(+)-ATPase.
Mattsson JP; Keeling DJ
Biochim Biophys Acta; 1996 Apr; 1280(1):98-106. PubMed ID: 8634321
[TBL] [Abstract][Full Text] [Related]
3. Substituted thieno[3,4-d]imidazoles, a novel group of H+/K(+)-ATPase inhibitors. Differentiation of their inhibition characteristics from those of omeprazole.
Beil W; Staar U; Sewing KF
Eur J Pharmacol; 1990 Oct; 187(3):455-67. PubMed ID: 1963594
[TBL] [Abstract][Full Text] [Related]
4. H(+)-ATPases of renal cortical and medullary endosomes are differentially sensitive to Sch-28080 and omeprazole.
Sabolić I; Brown D; Verbavatz JM; Kleinman J
Am J Physiol; 1994 Jun; 266(6 Pt 2):F868-77. PubMed ID: 7517642
[TBL] [Abstract][Full Text] [Related]
5. The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase.
David P; Nguyen H; Barbier A; Baron R
J Bone Miner Res; 1996 Oct; 11(10):1498-507. PubMed ID: 8889850
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationships of bafilomycin A1 derivatives as inhibitors of vacuolar H+-ATPase.
Gagliardi S; Gatti PA; Belfiore P; Zocchetti A; Clarke GD; Farina C
J Med Chem; 1998 May; 41(11):1883-93. PubMed ID: 9599238
[TBL] [Abstract][Full Text] [Related]
7. By 1023/SK&F 96022: biochemistry of a novel (H+ + K+)-ATPase inhibitor.
Simon WA; Keeling DJ; Laing SM; Fallowfield C; Taylor AG
Biochem Pharmacol; 1990 Jun; 39(11):1799-806. PubMed ID: 2160820
[TBL] [Abstract][Full Text] [Related]
8. Characterization of proton transport in bone-derived membrane vesicles.
Mattsson JP; Lorentzon P; Wallmark B; Keeling DJ
Biochim Biophys Acta; 1993 Feb; 1146(1):106-12. PubMed ID: 8443216
[TBL] [Abstract][Full Text] [Related]
9. Influence of bafilomycin A1 on pHi responses in cultured rabbit nonpigmented ciliary epithelium.
Wu Q; Delamere NA
Am J Physiol; 1997 Nov; 273(5):C1700-6. PubMed ID: 9374657
[TBL] [Abstract][Full Text] [Related]
10. H(+)-K(+)-ATPase of rat inner medullary collecting duct in primary culture.
Kleinman JG; Tipnis P; Pscheidt R
Am J Physiol; 1993 Nov; 265(5 Pt 2):F698-704. PubMed ID: 8238550
[TBL] [Abstract][Full Text] [Related]
11. A vacuolar-type proton pump energizes K+/H+ antiport in an animal plasma membrane.
Wieczorek H; Putzenlechner M; Zeiske W; Klein U
J Biol Chem; 1991 Aug; 266(23):15340-7. PubMed ID: 1831202
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of osteoclast proton transport by bafilomycin A1 abolishes bone resorption.
Sundquist K; Lakkakorpi P; Wallmark B; Väänänen K
Biochem Biophys Res Commun; 1990 Apr; 168(1):309-13. PubMed ID: 2139331
[TBL] [Abstract][Full Text] [Related]
13. Reversible and potent uncoupling of hog gastric (H(+)+K(+))-ATPase by prodigiosins.
Matsuya H; Okamoto M; Ochi T; Nishikawa A; Shimizu S; Kataoka T; Nagai K; Wasserman HH; Ohkuma S
Biochem Pharmacol; 2000 Dec; 60(12):1855-63. PubMed ID: 11108801
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity to vanadate and isoforms of subunits A and B distinguish the osteoclast proton pump from other vacuolar H+ ATPases.
Chatterjee D; Chakraborty M; Leit M; Neff L; Jamsa-Kellokumpu S; Fuchs R; Baron R
Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6257-61. PubMed ID: 1385872
[TBL] [Abstract][Full Text] [Related]
15. Omeprazole, a specific inhibitor of gastric (H+-K+)-ATPase, is a H+-activated oxidizing agent of sulfhydryl groups.
Im WB; Sih JC; Blakeman DP; McGrath JP
J Biol Chem; 1985 Apr; 260(8):4591-7. PubMed ID: 2985559
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity to nitrate and other oxyanions further distinguishes the vanadate-sensitive osteoclast proton pump from other vacuolar H(+)-ATPases.
Chatterjee D; Neff L; Chakraborty M; Fabricant C; Baron R
Biochemistry; 1993 Mar; 32(11):2808-12. PubMed ID: 8457547
[TBL] [Abstract][Full Text] [Related]
17. The catalytic cycle of the vacuolar H(+)-ATPase. Comparison of proton transport in kidney- and osteoclast-derived vesicles.
David P; Baron R
J Biol Chem; 1994 Dec; 269(48):30158-63. PubMed ID: 7982921
[TBL] [Abstract][Full Text] [Related]
18. Luminal acidification in K-replete OMCDi: contributions of H-K-ATPase and bafilomycin-A1-sensitive H-ATPase.
Armitage FE; Wingo CS
Am J Physiol; 1994 Sep; 267(3 Pt 2):F450-8. PubMed ID: 8092259
[TBL] [Abstract][Full Text] [Related]
19. Characterization of ATP-dependent proton transport in medullary bone-derived microsomes.
Sundquist K
Bone Miner; 1993 Jan; 20(1):17-29. PubMed ID: 8384039
[TBL] [Abstract][Full Text] [Related]
20. A vacuolar ATPase inhibitor, FR167356, prevents bone resorption in ovariectomized rats with high potency and specificity: potential for clinical application.
Niikura K; Takeshita N; Takano M
J Bone Miner Res; 2005 Sep; 20(9):1579-88. PubMed ID: 16059630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
